Practical Neurology

11/15/2025

🧠💤 Sleep-Related differ from parasomnias in both clinical impact & tx. Dr. Morris Chang's new article can help you to better recognize & manage SRMDs to improve patient QOL: https://ow.ly/uaTK50XpW8P
American Academy of Neurology (AAN) American Academy of Sleep Medicine International Parkinson and Movement Disorder Society American Medical Association

Sleep-Related Movement Disorders

11/14/2025

The U.S. Food and Drug Administration has granted Investigational Device Exemption for the system, an epicranial device for people with drug-resistant focal , authorizing the pivotal EASEE4US clinical study.
https://ow.ly/prEi50XrWR8
American Epilepsy Society Epilepsy Foundation of America American Academy of Neurology (AAN)

The Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for the EASEE4US clinical study, allowing PRECISIS (Hei…

11/13/2025

Our November issue with Medical Editor Joyce Matsumoto, MD (David Geffen School of Medicine at UCLA) explores therapies and strategies for the care of children and adults with epilepsy, from emerging options, to , , and more.

Read our new issue today: https://ow.ly/HML950XqMRF

American Epilepsy Society Epilepsy Foundation of America American Academy of Neurology (AAN) American Academy of Pediatrics Child Neurology Society

11/12/2025

Older nursing home residents who use both and a -inhibiting may have a higher risk of , according to research published in Neurology Journal.
https://ow.ly/S9iG50XqQhl
American Academy of Neurology (AAN) American Epilepsy Society Gerontological Society of America ASIPP American Society of Pain & Neuroscience

Older nursing home residents who take tramadol together with antidepressants that inhibit the CYP2D6 enzyme may face a higher risk of seizures, according …

11/12/2025

Treatment with the GLP-1 RA may reduce risk of recurrence for people with type 2 who have experienced minor acute stroke or , according to new research published in JAMA Internal Medicine.
https://ow.ly/JrtR50Xqi0U
Endovascular Today American Academy of Neurology (AAN)

Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide may reduce the risk of recurrent stroke and improve short-term function…

11/10/2025

can be differentiated from and using plasma N-glycan signatures—study results published in : Neuroimmunology and Neuroinflammation.
https://ow.ly/i8C050XoHcF
Neurology Journal National Multiple Sclerosis Society American Academy of Neurology (AAN)

Study results published in Neurology Neuroimmunology & Neuroinflammation demonstrated the utility of plasma N-glycan profiles in differentiating m

11/09/2025

For people with essential , -driven transcutaneous peripheral nerve stimulation therapy was associated with significant improvements in functional outcomes—data published in JAMA Neurology.
https://ow.ly/YxuQ50XoH4U
International Essential Tremor Foundation International Parkinson and Movement Disorder Society American Academy of Neurology (AAN)

For adults with essential tremor (ET), artificial intelligence (AI)-driven transcutaneous peripheral nerve stimulation (TPNS) therapy was associated with …

11/08/2025

The U.S. Food and Drug Administration has approved ( & ; UCB USA) as the first treatment for people with 2 deficiency.
https://ow.ly/g2KU50XoApA
American Academy of Neurology (AAN) Child Neurology Society American Association of Neuromuscular & Electrodiagnostic Medicine - AANEM My Mito Mission - Powering Awareness for Mitochondrial Disease

The Food and Drug Administration (FDA) has approved Kygevvi (doxecitine and doxribtimine; UCB, Brussels, Belgium) for the treatment of adult and pediatric…

11/07/2025

People with both periodontal disease and dental caries showed a significantly higher risk of , according to data published in Open Access.
https://ow.ly/77CH50Xo87C
American Academy of Neurology (AAN) Neurology Journal Endovascular Today American Dental Association

The results of a new study published in Neurology Open Access demonstrated that people who have periodontal disease and dental caries have a substantially…

11/05/2025

(Roche) has been cleared by the U.S. Food and Drug Administration to help clinicians rule out -related or pathology for individuals aged 55 years and older.
https://ow.ly/8iNB50XnvzP
Alzheimer's Association American Academy of Neurology (AAN)

The Food and Drug Administration (FDA) has granted 510(k) clearance to Elecsys pTau181 (Roche, Basel, Switzerland), the first blood-based biomarker assay …

11/04/2025

The U.S. Food and Drug Administration has accepted the New Drug Application for MK-6240 ( ), a PET imaging device that detects neurofibrillary tangles in people with cognitive impairment under evaluation for 's.
https://ow.ly/k1zS50XmPA4
Alzheimer's Association American Academy of Neurology (AAN)

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for MK-6240 (Lantheus Holdings, Bedford, MA), an investigational F18-la…